Florida Cancer Specialists & Research Institute Announces Executive Leadership Appointment

Fort Myers, Fla., October 26, 2022 — Florida Cancer Specialists & Research Institute (FCS) pleased to announce that Josh Eaves has been appointed as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker. Josh joined FCS earlier this year as Senior Vice President Corporate Development. In his new role, Josh will continue steering new business development initiatives including strategic partnerships and expansion opportunities to improve the patient experience throughout FCS while positively impacting value of the organization as a whole.

“Josh has developed a solid strategy for our practice that will support future growth and innovation, delving into new markets, partnerships and services,” remarked FCS Chief Executive Officer Nathan H. Walcker. “His continued leadership will enable us to forge ahead, keeping FCS at the forefront of oncology care on a global scale.”

Eaves is an experienced business development and sales professional, skilled at developing strategies to create regional networks that provide oncology coverage to local communities.

Prior to joining FCS, he served as Senior Vice President of Business Development for Alliance Oncology in Nashville, TN where he championed partnerships with health systems to develop oncology networks, to expand patient access and enhance patient experience. He led the business development and implementation team, driving the acquisition process from start to finish. Josh was also a driving force in efforts to deepen the scope of services in existing markets, developing cost models for bundled payments and value-based care contracts with payers.

He previously held positions with Nashville-based US Radiosurgery/Neospine prior to being acquired by Alliance Oncology in business development for stereotactic radiosurgery facilities. He began his career in business development for e+ healthcare, expanding PET/CT scanning services at an international level.

Josh holds a Bachelor of Arts from Vanderbilt University.

Read his full bio here: https://flcancer.com/staff/josh-eaves/

# # #

About Florida Cancer Specialists & Research Institute
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past 5 years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with Florida Cancer Specialists participation. * Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.

Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments, including targeted therapies, genomic-based treatment, and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.

*Prior to approval

For More Information:
Michelle Robey, Vice President of Marketing
Michelle.Robey@FLCancer.com
(813) 767-9398

Jennifer Bradley, Corporate Communications Director
Jennifer.Bradley@FLCancer.com
(847) 280-1740